9
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Orthopaedic Systems Response to and Return from the COVID-19 Pandemic : Lessons for Future Crisis Management

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract:

          The coronavirus disease 2019 (COVID-19) pandemic has become the dominant health-care issue of this generation and has reached every corner of the health-care delivery spectrum. Our 3 orthopaedic departments enacted a response to the COVID-19 pandemic within our organizations. We discuss our health-care systems’ response to the outbreak and offer discussion for the recovery of the orthopaedic service line within large health-care systems.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic

          New England Journal of Medicine
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

            Abstract Background The emergence of coronavirus disease 2019 (COVID-19) is a major healthcare threat. The current method of detection involves a quantitative polymerase chain reaction (qPCR)–based technique, which identifies the viral nucleic acids when present in sufficient quantity. False-negative results can be achieved and failure to quarantine the infected patient would be a major setback in containing the viral transmission. We aim to describe the time kinetics of various antibodies produced against the 2019 novel coronavirus (SARS-CoV-2) and evaluate the potential of antibody testing to diagnose COVID-19. Methods The host humoral response against SARS-CoV-2, including IgA, IgM, and IgG response, was examined by using an ELISA-based assay on the recombinant viral nucleocapsid protein. 208 plasma samples were collected from 82 confirmed and 58 probable cases (qPCR negative but with typical manifestation). The diagnostic value of IgM was evaluated in this cohort. Results The median duration of IgM and IgA antibody detection was 5 (IQR, 3–6) days, while IgG was detected 14 (IQR, 10–18) days after symptom onset, with a positive rate of 85.4%, 92.7%, and 77.9%, respectively. In confirmed and probable cases, the positive rates of IgM antibodies were 75.6% and 93.1%, respectively. The detection efficiency by IgM ELISA is higher than that of qPCR after 5.5 days of symptom onset. The positive detection rate is significantly increased (98.6%) when combining IgM ELISA assay with PCR for each patient compared with a single qPCR test (51.9%). Conclusions The humoral response to SARS-CoV-2 can aid in the diagnosis of COVID-19, including subclinical cases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

              Background The outbreak of 2019 novel coronavirus disease (COVID-19) in Wuhan, China, has spread rapidly worldwide. In the early stage, we encountered a small but meaningful number of patients who were unintentionally scheduled for elective surgeries during the incubation period of COVID-19. We intended to describe their clinical characteristics and outcomes. Methods We retrospectively analyzed the clinical data of 34 patients underwent elective surgeries during the incubation period of COVID-19 at Renmin Hospital, Zhongnan Hospital, Tongji Hospital and Central Hospital in Wuhan, from January 1 to February 5, 2020. Findings Of the 34 operative patients, the median age was 55 years (IQR, 43–63), and 20 (58·8%) patients were women. All patients developed COVID-19 pneumonia shortly after surgery with abnormal findings on chest computed tomographic scans. Common symptoms included fever (31 [91·2%]), fatigue (25 [73·5%]) and dry cough (18 [52·9%]). 15 (44·1%) patients required admission to intensive care unit (ICU) during disease progression, and 7 patients (20·5%) died after admission to ICU. Compared with non-ICU patients, ICU patients were older, were more likely to have underlying comorbidities, underwent more difficult surgeries, as well as more severe laboratory abnormalities (eg, hyperleukocytemia, lymphopenia). The most common complications in non-survivors included ARDS, shock, arrhythmia and acute cardiac injury. Interpretation In this retrospective cohort study of 34 operative patients with confirmed COVID-19, 15 (44·1%) patients needed ICU care, and the mortality rate was 20·5%. Funding National Natural Science Foundation of China.
                Bookmark

                Author and article information

                Journal
                J Bone Joint Surg Am
                J Bone Joint Surg Am
                jbjsam
                The Journal of Bone and Joint Surgery. American Volume
                Journal of Bone and Joint Surgery, Inc.
                0021-9355
                1535-1386
                11 May 2020
                : 10.2106/JBJS.20.00709
                Affiliations
                [1 ]Kaiser Permanente Southern California, Harbor City, California
                [2 ]Kaiser Permanente Southern California, San Diego, California
                [3 ]Kaiser Permanente Southern California, Los Angeles, California
                [4 ]University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
                [5 ]University of Arizona College of Medicine–Phoenix, Phoenix, Arizona
                [6 ]Banner Health, Phoenix Arizona
                Author notes
                [a ]Email address for R.A. Navarro: ronald.a.navarro@ 123456kp.org
                Author information
                http://orcid.org/0000-0003-1869-6440
                http://orcid.org/0000-0001-6966-5068
                http://orcid.org/0000-0002-2908-6659
                http://orcid.org/0000-0002-2091-7743
                http://orcid.org/0000-0001-7821-4269
                http://orcid.org/0000-0003-4306-4090
                http://orcid.org/0000-0002-1035-6751
                Article
                JBJS-D-20-00709
                10.2106/JBJS.20.00709
                7396222
                32675663
                1f984ce6-e205-48f9-a182-a21c492189a9
                Copyright © 2020 by The Journal of Bone and Joint Surgery, Incorporated

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Page count
                Pages: 8
                Categories
                0180
                The Orthopaedic Forum
                Custom metadata
                ONLINE-ONLY

                Comments

                Comment on this article